The forecast indicates a steady decline in hospital discharges for leiomyoma of the uterus in Italy from 2024 to 2028, with a consistent decrease from 108.0 discharges per hundred thousand persons in 2024 to 100.0 by 2028. Comparing to 2023, where the value was slightly higher than 108, this reflects a continuous downward trend. The year-on-year percentage variation showcases a drop of approximately 1.94% annually from 2024 to 2025, and a similar pattern continues in the following years. The average Compound Annual Growth Rate (CAGR) over these five years is a decrease of approximately 1.89% per annum.

Future Trends to Watch:

Potential advancements in non-invasive treatments could further lower hospital discharges.
Shifts in healthcare policy or population health initiatives might influence discharge rates.
Demographic changes, such as an aging population, could impact future trends.